164 related articles for article (PubMed ID: 32486849)
1.
Xiao YS; Tong HZ; Yuan XH; Xiong CH; Xu XY; Zeng YF
Exp Biol Med (Maywood); 2020 Aug; 245(14):1233-1241. PubMed ID: 32486849
[TBL] [Abstract][Full Text] [Related]
2. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
Li C; He X; Zhang L; Li L; Zhao W
BMC Cancer; 2019 Oct; 19(1):957. PubMed ID: 31615475
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA in colorectal cancer.
Li T; Wang WC; McAlister V; Zhou Q; Zheng X
J Cell Mol Med; 2021 Apr; 25(8):3667-3679. PubMed ID: 33687140
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
Liu Y; Zhang M; Liang L; Li J; Chen YX
Int J Clin Exp Pathol; 2015; 8(9):11480-4. PubMed ID: 26617879
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
7. Circular noncoding RNA circMBOAT2 is a novel tumor marker and regulates proliferation/migration by sponging miR-519d-3p in colorectal cancer.
Tang X; Sun G; He Q; Wang C; Shi J; Gao L; Ye J; Liang Y; Qu H
Cell Death Dis; 2020 Aug; 11(8):625. PubMed ID: 32796815
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
Yu MH; Luo Y; Qin SL; Zhong M
Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
[TBL] [Abstract][Full Text] [Related]
9. Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer.
Hu M; Ou-Yang W; Jing D; Chen R
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414766
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
13. Circular RNAs: The crucial regulatory molecules in colorectal cancer.
Zeng K; Wang S
Pathol Res Pract; 2020 Apr; 216(4):152861. PubMed ID: 32061452
[TBL] [Abstract][Full Text] [Related]
14. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_001659 serves as a novel diagnostic and prognostic biomarker for colorectal cancer.
He B; Chao W; Huang Z; Zeng J; Yang J; Luo D; Huang S; Pan H; Hao Y
Biochem Biophys Res Commun; 2021 Apr; 551():100-106. PubMed ID: 33725570
[TBL] [Abstract][Full Text] [Related]
16. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
[TBL] [Abstract][Full Text] [Related]
17. Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer.
Weng W; Liu N; Toiyama Y; Kusunoki M; Nagasaka T; Fujiwara T; Wei Q; Qin H; Lin H; Ma Y; Goel A
Mol Cancer; 2018 Jan; 17(1):16. PubMed ID: 29382334
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
[TBL] [Abstract][Full Text] [Related]
19. CK1α overexpression correlates with poor survival in colorectal cancer.
Richter J; Kretz AL; Lemke J; Fauler M; Werner JU; Paschke S; Leithäuser F; Henne-Bruns D; Hillenbrand A; Knippschild U
BMC Cancer; 2018 Feb; 18(1):140. PubMed ID: 29409464
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced hsa_circ_0000826 is linked to liver metastasis of colorectal cancer.
Shi L; Tao C; Tang Y; Xia Y; Li X; Wang X
J Clin Lab Anal; 2020 Sep; 34(9):e23405. PubMed ID: 32633429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
